Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Testing effectiveness (Phase 2)Ended earlyNCT00358319
What this trial is testing

Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma

Who this might be right for
Malignant Melanoma
H. Lee Moffitt Cancer Center and Research Institute 42
Not applicableStudy completedNCT01730365
What this trial is testing

Optical Detection of Malignancy During Percutaneous Interventions

Who this might be right for
Pulmonary Coin LesionColon Cancer Liver MetastasisBreast Cancer
Philips Healthcare 104
Testing effectiveness (Phase 2)Study completedNCT03314805
What this trial is testing

PG2 Breast Cancer Evaluation in Adjuvant Medicine Study

Who this might be right for
Cancer-related FatigueNeutropenia, Malignant
PhytoHealth Corporation 67
Testing effectiveness (Phase 2)UnknownNCT04884997
What this trial is testing

Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma

Who this might be right for
Malignant Melanoma
First Affiliated Hospital of Zhejiang University 90
Not applicableStudy completedNCT04377360
What this trial is testing

Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors

Who this might be right for
Malignant Skin TumorSoft Tissue Tumor, Malignant
Alpha Tau Medical LTD. 10
Testing effectiveness (Phase 2)WithdrawnNCT01355562
What this trial is testing

Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer

Who this might be right for
MelanomaMetastatic Kidney Cancer
Loma Linda University
Testing effectiveness (Phase 2)UnknownNCT03599960
What this trial is testing

Combination Chemotherapy in Patients With Newly Diagnosed BPDCN

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Centre Hospitalier Universitaire de Besancon 26
Testing effectiveness (Phase 2)Study completedNCT00066196
What this trial is testing

Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma

Who this might be right for
MelanomaMalignant Metastatic Melanoma
MedImmune LLC 110
Large-scale testing (Phase 3)Ended earlyNCT00089141
What this trial is testing

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Cancer
Martin, Paul 151
Testing effectiveness (Phase 2)Study completedNCT00256282
What this trial is testing

Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

Who this might be right for
Metastatic Melanoma
John P. Fruehauf 52
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT02083354
What this trial is testing

Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma

Who this might be right for
CancerMelanoma
Novartis Pharmaceuticals 77
Not applicableUnknownNCT05602337
What this trial is testing

A Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a Hx of Skin Cancer

Who this might be right for
Melanoma and Other Malignant Neoplasms of Skin
DermTech 180
Not applicableUnknownNCT03062072
What this trial is testing

Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients

Who this might be right for
CancerColon CancerBreast Cancer+1 more
National Cancer Center, Korea 300
Very early researchEnded earlyNCT02591654
What this trial is testing

MRI and PET to Assess Pembrolizumab Response

Who this might be right for
Malignant Melanoma, Metastatic
Columbia University 6
Not applicableLooking for participantsNCT00477100
What this trial is testing

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

Who this might be right for
Inflammatory Breast CarcinomaInvasive Breast CarcinomaSecond Primary Malignant Neoplasm
M.D. Anderson Cancer Center 1,200
Large-scale testing (Phase 3)Study completedNCT00039000
What this trial is testing

Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma

Who this might be right for
Malignant Melanoma
Agenus Inc. 350
Early research (Phase 1)Active Not RecruitingNCT03168737
What this trial is testing

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

Who this might be right for
Malignant Breast NeoplasmMalignant Colorectal NeoplasmMalignant Pancreatic Neoplasm+1 more
M.D. Anderson Cancer Center 25
Not applicableLooking for participantsNCT06310330
What this trial is testing

TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography

Who this might be right for
Breast Neoplasm Malignant Primary
Norwegian University of Science and Technology 250
Next Page